Product Information
LANTHANUM CARB 1,000 MG TB CHW is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $3.1513 per EA under NDC 00093594098. Its NADAC has been published 217 times since Aug 10, 2022.
FDA first approved this application on Jan 27, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1000 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093594098
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LANTHANUM CARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA090977FDA Approved
1/27/2022
TE Code
AB
On Market Since
5/25/2022
Pharmacological Classes
Price Statistics
The NADAC for LANTHANUM CARB 1,000 MG TB CHW has been published 217 times since Aug 10, 2022, and over the history we have for it it has declined 56.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1513 per EA |
|---|---|
| All-time high | $7.4312 (Apr 10, 2024) |
| All-time low | $3.0689 (Aug 19, 2026) |
| 52-week high | $4.8117 |
| 52-week low | $3.0689 |
| Median price | $4.5442 |
| Average price | $4.8905 |
| Largest weekly change | +41.1% (Jan 17, 2024) |
| Weeks tracked | 217 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Lanthanum carbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lanthanum carbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phosphate Binder class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LANTHANUM CARB 1,000 MG TB CHW?
The current National Average Drug Acquisition Cost (NADAC) for LANTHANUM CARB 1,000 MG TB CHW, manufactured by Teva Pharmaceuticals USA Inc., is $3.1513 per EA (NDC 00093594098), effective Sep 30, 2026.
How has the price of LANTHANUM CARB 1,000 MG TB CHW changed over time?
Over the history we have for it, the NADAC for LANTHANUM CARB 1,000 MG TB CHW has declined 56.6%. It has been tracked across 217 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for LANTHANUM CARB 1,000 MG TB CHW?
Since Aug 10, 2022, the NADAC for LANTHANUM CARB 1,000 MG TB CHW has ranged from a low of $3.0689 (Aug 19, 2026) to a high of $7.4312 (Apr 10, 2024), with a median of $4.5442 per EA.
Are there cheaper alternatives to LANTHANUM CARB 1,000 MG TB CHW?
No other NADAC-published product currently shares the active ingredient and strength of LANTHANUM CARB 1,000 MG TB CHW in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LANTHANUM CARB 1,000 MG TB CHW?
LANTHANUM CARB 1,000 MG TB CHW (NDC 00093594098) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.